COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 1851: Articles 18501-18510  | Next

Longitudinal analyses reveal age-specific immune correlates of COVID-19 severity
Lewis, S. A., Sureshchandra, S., Zulu, M. Z., Doratt, B., Pinski, A., Curtis, M., Jankeel, A., Ibraim, I., Rhoades, N., Jiang, X., Tifrea, D., Zaldivar, F., Shen, W., Edwards, R., Chow, D., Cooper, D., Amin, A., Messaoudi, I.
10.1101/2021.01.25.21250189 — Posted: 2021-01-30
Development and external validation of prognostic models for COVID-19 to support risk stratification in secondary care
Adderley, N. J., Taverner, T., Price, M., Sainsbury, C., Greenwood, D., Chandan, J. S., Takwoingi, Y., Haniffa, R., Hosier, I., Welch, C., Parekh, D., Gallier, S., Gokhale, K. M., Denniston, A. K., Sapey, E., Nirantharakumar, K.
10.1101/2021.01.25.21249942 — Posted: 2021-01-30
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
Malherbe, D. C., Kurup, D., Wirblich, C., Ronk, A. J., Mire, C., Kuzmina, N., Shaik, N., Periasamy, S., Hyde, M. A., Williams, J. M., Shi, P.-Y., Schnell, M. J., Bukreyev, A.
10.1101/2021.01.29.428442 — Posted: 2021-01-30
SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques
Roozendaal, R., Solforosi, L., Stieh, D., Serroyen, J., Straetemans, R., Wegmann, F., Rosendahl Huber, S. K., van der Lubbe, J. E. M., Hendriks, J., le Gars, M., Dekking, L., Czapska-Casey, D. N., Guimera, N., Janssen, S., Tete, S., Chandrashekar, A., Mercado, N., Yu, J., Koudstaal, W., Sadoff, J., Barouch, D. H., Schuitemaker, H., Zahn, R.
10.1101/2021.01.30.428921 — Posted: 2021-01-30 Discussion: Onsite
Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii
Berndt, A. J., Smalley, T. N., Ren, B., Badary, A., Sproles, A., Fields, F., Torres-Tiji, Y., Heredia, V., Mayfield, S. P.
10.1101/2021.01.29.428890 — Posted: 2021-01-30
The evolutionary making of SARS-CoV-2
Iruegas Lopez, R., Dosch, J., Sikora, M., Hummer, G., Covino, R., Ebersberger, I.
10.1101/2021.01.29.428808 — Posted: 2021-01-29
Information retrieval in an infodemic: the case of COVID-19 publications
Ferdowsi, S., Borissov, N., Kashani, E., Vicente Alvarez, D., Copara, J., Gouareb, R., Amini, P., Teodoro, D.
10.1101/2021.01.29.428847 — Posted: 2021-01-29
Recombination and low-diversity confound homoplasy-based methods to detect the effect of SARS-CoV-2 mutations on viral transmissibility
Giorgi, E. E., Bhattacharya, T., Fischer, W. M., Yoon, H., Abfalterer, W., Korber, B.
10.1101/2021.01.29.428535 — Posted: 2021-01-29
Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets
Kim, Y.-I., Kim, D., Yu, K.-M., Seo, H. D., Lee, S.-A., Casel, M. A. B., Jang, S.-G., Kim, S., Jung, W., Lai, C.-J., Choi, Y. K., Jung, J. U.
10.1101/2021.01.28.428743 — Posted: 2021-01-29
Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce superior immune responses than single dose vaccine regimens in mice
Spencer, A. J., McKay, P. F., Belij-Rammerstorfer, S., Ulaszewska, M., Bissett, C. D., Hu, K., Samnuan, K., Sharpe, H. R., Wright, D., Gilbride, C., Truby, A., Allen, E. R., Gilbert, S. C., Shattock, R. J., Lambe, T.
10.1101/2021.01.28.428665 — Posted: 2021-01-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).